WS
VRTX icon

Wedbush Securities’s Vertex Pharmaceuticals VRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.95M Buy
6,622
+19
+0.3% +$8.46K 0.1% 147
2025
Q1
$3.2M Buy
6,603
+317
+5% +$154K 0.12% 130
2024
Q4
$2.53M Sell
6,286
-58
-0.9% -$23.4K 0.09% 161
2024
Q3
$2.95M Sell
6,344
-247
-4% -$115K 0.11% 137
2024
Q2
$3.09M Buy
6,591
+381
+6% +$179K 0.11% 136
2024
Q1
$2.6M Buy
6,210
+290
+5% +$121K 0.1% 157
2023
Q4
$2.41M Buy
5,920
+1,258
+27% +$512K 0.11% 140
2023
Q3
$1.62M Buy
4,662
+503
+12% +$175K 0.08% 188
2023
Q2
$1.46M Sell
4,159
-740
-15% -$260K 0.07% 222
2023
Q1
$1.54M Buy
4,899
+99
+2% +$31.2K 0.08% 204
2022
Q4
$1.39M Buy
4,800
+127
+3% +$36.7K 0.08% 220
2022
Q3
$1.35M Buy
4,673
+423
+10% +$122K 0.08% 211
2022
Q2
$1.2M Sell
4,250
-1,272
-23% -$359K 0.07% 250
2022
Q1
$1.44M Sell
5,522
-165
-3% -$43.1K 0.07% 251
2021
Q4
$1.25M Sell
5,687
-2,428
-30% -$533K 0.05% 299
2021
Q3
$1.47M Buy
8,115
+46
+0.6% +$8.34K 0.07% 252
2021
Q2
$1.63M Buy
8,069
+1,101
+16% +$222K 0.08% 235
2021
Q1
$1.5M Buy
6,968
+396
+6% +$85.1K 0.08% 223
2020
Q4
$1.55M Sell
6,572
-118
-2% -$27.9K 0.14% 154
2020
Q3
$1.82M Sell
6,690
-2,697
-29% -$734K 0.17% 118
2020
Q2
$2.73M Buy
9,387
+149
+2% +$43.3K 0.26% 80
2020
Q1
$2.2M Sell
9,238
-58
-0.6% -$13.8K 0.26% 85
2019
Q4
$2.04M Sell
9,296
-30
-0.3% -$6.57K 0.18% 130
2019
Q3
$1.58M Buy
9,326
+207
+2% +$35.1K 0.15% 153
2019
Q2
$1.67M Sell
9,119
-97
-1% -$17.8K 0.17% 142
2019
Q1
$1.7M Sell
9,216
-208
-2% -$38.3K 0.18% 122
2018
Q4
$1.56M Sell
9,424
-166
-2% -$27.5K 0.2% 125
2018
Q3
$1.85M Buy
9,590
+145
+2% +$27.9K 0.21% 100
2018
Q2
$1.61M Sell
9,445
-977
-9% -$166K 0.2% 108
2018
Q1
$1.7M Buy
10,422
+215
+2% +$35K 0.22% 105
2017
Q4
$1.53M Buy
10,207
+2,154
+27% +$323K 0.19% 118
2017
Q3
$1.22M Sell
8,053
-11
-0.1% -$1.67K 0.16% 136
2017
Q2
$1.04M Buy
+8,064
New +$1.04M 0.13% 180
2017
Q1
Sell
-4,238
Closed -$312K 883
2016
Q4
$312K Sell
4,238
-3,456
-45% -$254K 0.05% 485
2016
Q3
$671K Buy
+7,694
New +$671K 0.1% 236